Tag archive for ‘Active Biotech (NASDAQ OMX NORDIC:ACTI)’
Ilan Shavit On Tuesday, October 1st, 2013

Oral Laquinimod for Multiple Sclerosis May Reduce Brain Damage Caused by Neurodegeneration

  – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Active Biotech (NASDAQ OMX NORDIC:ACTI) announced today the publication of a pre-planned analysis of the Phase III ALLEGRO study demonstrating More...

Wordpress site Developed by Fixing WordPress Problems